262 related articles for article (PubMed ID: 17391391)
21. Incidence of inducible clindamycin resistance in staphylococci: first results from Turkey.
Azap OK; Arslan H; Timurkaynak F; Yapar G; Oruç E; Gagir U
Clin Microbiol Infect; 2005 Jul; 11(7):582-4. PubMed ID: 15966979
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of macrolide-lincosamide-streptogramin B resistance phenotypes in enterococci.
Min YH; Jeong JH; Choi YJ; Yun HJ; Lee K; Shim MJ; Kwak JH; Choi EC
Antimicrob Agents Chemother; 2003 Nov; 47(11):3415-20. PubMed ID: 14576096
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of resistance to macrolide, lincosamide and streptogramin antibiotics in Gram-positive cocci isolated in a Korean hospital.
Lim JA; Kwon AR; Kim SK; Chong Y; Lee K; Choi EC
J Antimicrob Chemother; 2002 Mar; 49(3):489-95. PubMed ID: 11864949
[TBL] [Abstract][Full Text] [Related]
24. Purification and biochemical characterization of the ErmSF macrolide-lincosamide-streptogramin B resistance factor protein expressed as a hexahistidine-tagged protein in Escherichia coli.
Jin HJ; Yang YD
Protein Expr Purif; 2002 Jun; 25(1):149-59. PubMed ID: 12071710
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial resistance of coagulase-negative staphylococci from bovine subclinical mastitis with particular reference to macrolide-lincosamide resistance phenotypes and genotypes.
Lüthje P; Schwarz S
J Antimicrob Chemother; 2006 May; 57(5):966-9. PubMed ID: 16524893
[TBL] [Abstract][Full Text] [Related]
26. [Phenotypes of macrolide, lincosamide, and streptogramin resistant Streptococcus viridans isolated from blood].
Rodríguez-Avial C; García MM; Rodríguez-Avial I; Picazo JJ
Rev Esp Quimioter; 1999 Dec; 12(4):346-51. PubMed ID: 10855014
[TBL] [Abstract][Full Text] [Related]
27. Genetic diversity of macrolides resistant Staphylococcus aureus clinical isolates and the potential synergistic effect of vitamins, C and K
El-Banna TE; Sonbol FI; Kamer AMA; Badr SAMM
BMC Microbiol; 2024 Jan; 24(1):30. PubMed ID: 38245680
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic and molecular characterization of macrolide and streptogramin resistance in Streptococcus mitis from neutropenic patients.
Achour W; Guenni O; Malbruny B; Canu A; Leclercq R; Hassen AB
J Antimicrob Chemother; 2004 Jul; 54(1):117-21. PubMed ID: 15190021
[TBL] [Abstract][Full Text] [Related]
29. Microarray analysis of erythromycin resistance determinants.
Volokhov D; Chizhikov V; Chumakov K; Rasooly A
J Appl Microbiol; 2003; 95(4):787-98. PubMed ID: 12969293
[TBL] [Abstract][Full Text] [Related]
30. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
[TBL] [Abstract][Full Text] [Related]
31. Resistance to macrolide-lincosamide-streptogramin antibiotics in enterococci from the intestines of animals.
Dutta GN; Devriese LA
Res Vet Sci; 1982 Jul; 33(1):70-2. PubMed ID: 6813931
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of resistance mechanisms against macrolides and lincosamides in methicillin-resistant coagulase-negative staphylococci in the Czech Republic and occurrence of an undefined mechanism of resistance to lincosamides.
Novotna G; Adamkova V; Janata J; Melter O; Spizek J
Antimicrob Agents Chemother; 2005 Aug; 49(8):3586-9. PubMed ID: 16048992
[TBL] [Abstract][Full Text] [Related]
33. Occurrence of macrolide-lincosamide-streptogramin resistances among staphylococcal clinical isolates at a university medical center. Is false susceptibility to new macrolides and clindamycin a contemporary clinical and in vitro testing problem?
Sanchez ML; Flint KK; Jones RN
Diagn Microbiol Infect Dis; 1993; 16(3):205-13. PubMed ID: 8477574
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of telithromycin, quinupristin/dalfopristin, linezolid and comparator antimicrobial agents against Staphylococcus aureus clinical isolates.
Millán L; Cerdá P; Rubio MC; Goñi P; Canales M; Capilla S; Oca M; Gómez-Lus R
J Chemother; 2004 Jun; 16(3):230-7. PubMed ID: 15330317
[TBL] [Abstract][Full Text] [Related]
35. [Study of macrolide, lincosamide, and streptogramin B antibiotics resistance in Staphylococcus aureus].
Matsuoka M
Yakugaku Zasshi; 2000 Apr; 120(4):374-86. PubMed ID: 10774259
[TBL] [Abstract][Full Text] [Related]
36. [Resistance to macrolide antibiotics found in methicillin-resistant Japanese clinical isolates of Staphylococcus aureus in 1996].
Nakamura A; Taniguchi K; Tsurubuchi K; O'Hara K; Sawai T
Jpn J Antibiot; 1998 Jul; 51(7):494-500. PubMed ID: 9755433
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial resistance in Staphylococcus aureus at the University of Chicago Hospitals: a 15-year longitudinal assessment in a large university-based hospital.
Seal JB; Moreira B; Bethel CD; Daum RS
Infect Control Hosp Epidemiol; 2003 Jun; 24(6):403-8. PubMed ID: 12828315
[TBL] [Abstract][Full Text] [Related]
38. Macrolide resistance phenotypes of commensal viridans group streptococci and Gemella spp. and PCR detection of resistance genes.
Cerdá Zolezzi P; Rubio Calvo MC; Millán L; Goñi P; Canales M; Capilla S; Durán E; Gómez-Lus R
Int J Antimicrob Agents; 2004 Jun; 23(6):582-9. PubMed ID: 15194129
[TBL] [Abstract][Full Text] [Related]
39. Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues.
Elliott RL; Pireh D; Griesgraber G; Nilius AM; Ewing PJ; Bui MH; Raney PM; Flamm RK; Kim K; Henry RF; Chu DT; Plattner JJ; Or YS
J Med Chem; 1998 May; 41(10):1651-9. PubMed ID: 9572890
[TBL] [Abstract][Full Text] [Related]
40. A dyadic plasmid that shows MLS and PMS resistance in Staphylococcus aureus.
Matsuoka M; Endou K; Kobayashi H; Inoue M; Nakajima Y
FEMS Microbiol Lett; 1997 Mar; 148(1):91-6. PubMed ID: 9066116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
